Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+–XO–ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81030002, 81270186, 81441008, 8160020014)

This publication has 57 references indexed in Scilit: